在意大利首次COVID-19大流行期间提供家庭癌症护理:案例系列研究(DomOnCOVID项目)

R. Passalacqua, M. Ratti, M. Bonomi, G. Grizzi, F. Negri, F. Crea, M. Giganti, B. Perrucci, M. Brighenti, S. Panni, M. Donini, A. Curti, D. Spada, R. Marchi, G. Donati, J. Saleri, M. Nazzari, G. Pogliacomi, F. Diodati, C. Caminiti
{"title":"在意大利首次COVID-19大流行期间提供家庭癌症护理:案例系列研究(DomOnCOVID项目)","authors":"R. Passalacqua, M. Ratti, M. Bonomi, G. Grizzi, F. Negri, F. Crea, M. Giganti, B. Perrucci, M. Brighenti, S. Panni, M. Donini, A. Curti, D. Spada, R. Marchi, G. Donati, J. Saleri, M. Nazzari, G. Pogliacomi, F. Diodati, C. Caminiti","doi":"10.31487/j.cor.2021.06.05","DOIUrl":null,"url":null,"abstract":"Background: Cancer represents a major risk factor for COVID-19 poor outcomes. During the crucial phase \nof the pandemic, we launched a home care project, called DomOnCOVID, aiming to provide care to patients \nin their own homes, enabling to keep immunocompromised individuals away from health care facilities, \ndecrease hospital use, and strengthen hospital capacity for subjects with COVID-19 and other conditions. \nThis paper describes this intervention in terms of feasibility and clinical outcomes.\nMethods: This is a descriptive study of cancer patients with confirmed or suspected COVID-19 infection \nassisted at home in the Italian Province of Cremona during the pandemic’s first peak. We devised an \norganizational home care system which included a medical and nursing team equipped with a car for home \nvisits, and a nurse manager who screened patient calls requesting inclusion in the project. The team \nadministered oral drugs at home (chemotherapy, TKis, etc.) and was equipped with all necessary tools to \nconduct examinations, check vital signs, take blood samples, and nasopharyngeal swabs for COVID-19 \ntesting. \nResults: From March 23rd to May 15th 2020, 71 cancer patients were assisted at home (181 visits, mean \n2.5, SD 1.6 range 1-7). All had symptoms that could be traced back to COVID infection, but only 26/71 \n(37%) were found to be COVID+; 19/26 (73%) had mild symptoms, while 7 with severe symptoms were \nhospitalized and 2 died for COVID-19. The remaining patients recovered. 43/71 (60%) received at home \noral or subcutaneous drugs and no particular problems or toxicity were observed. 16/28 (57%) of individuals \nliving with COVID+ patients were found to be COVID+, while none of the non-cohabiting were COVID+. \nConclusion: Delivery of cancer care at home is feasible and may be particularly useful not only during \nhealth crises but also after the epidemic in order to reduce hospital access, patient and care-giver travel and \nimprove their quality of life. Further implementation studies on home-based care in oncology are warranted.\n","PeriodicalId":10487,"journal":{"name":"Clinical Oncology and Research","volume":"53 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Delivery of Cancer Care at Home during the First COVID-19 Pandemic in Italy: A Case Series Study (DomOnCOVID Project)\",\"authors\":\"R. Passalacqua, M. Ratti, M. Bonomi, G. Grizzi, F. Negri, F. Crea, M. Giganti, B. Perrucci, M. Brighenti, S. Panni, M. Donini, A. Curti, D. Spada, R. Marchi, G. Donati, J. Saleri, M. Nazzari, G. Pogliacomi, F. Diodati, C. Caminiti\",\"doi\":\"10.31487/j.cor.2021.06.05\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Cancer represents a major risk factor for COVID-19 poor outcomes. During the crucial phase \\nof the pandemic, we launched a home care project, called DomOnCOVID, aiming to provide care to patients \\nin their own homes, enabling to keep immunocompromised individuals away from health care facilities, \\ndecrease hospital use, and strengthen hospital capacity for subjects with COVID-19 and other conditions. \\nThis paper describes this intervention in terms of feasibility and clinical outcomes.\\nMethods: This is a descriptive study of cancer patients with confirmed or suspected COVID-19 infection \\nassisted at home in the Italian Province of Cremona during the pandemic’s first peak. We devised an \\norganizational home care system which included a medical and nursing team equipped with a car for home \\nvisits, and a nurse manager who screened patient calls requesting inclusion in the project. The team \\nadministered oral drugs at home (chemotherapy, TKis, etc.) and was equipped with all necessary tools to \\nconduct examinations, check vital signs, take blood samples, and nasopharyngeal swabs for COVID-19 \\ntesting. \\nResults: From March 23rd to May 15th 2020, 71 cancer patients were assisted at home (181 visits, mean \\n2.5, SD 1.6 range 1-7). All had symptoms that could be traced back to COVID infection, but only 26/71 \\n(37%) were found to be COVID+; 19/26 (73%) had mild symptoms, while 7 with severe symptoms were \\nhospitalized and 2 died for COVID-19. The remaining patients recovered. 43/71 (60%) received at home \\noral or subcutaneous drugs and no particular problems or toxicity were observed. 16/28 (57%) of individuals \\nliving with COVID+ patients were found to be COVID+, while none of the non-cohabiting were COVID+. \\nConclusion: Delivery of cancer care at home is feasible and may be particularly useful not only during \\nhealth crises but also after the epidemic in order to reduce hospital access, patient and care-giver travel and \\nimprove their quality of life. Further implementation studies on home-based care in oncology are warranted.\\n\",\"PeriodicalId\":10487,\"journal\":{\"name\":\"Clinical Oncology and Research\",\"volume\":\"53 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Oncology and Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31487/j.cor.2021.06.05\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Oncology and Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31487/j.cor.2021.06.05","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:癌症是COVID-19不良预后的主要风险因素。在大流行的关键阶段,我们启动了一个名为DomOnCOVID的家庭护理项目,旨在为患者在自己家中提供护理,使免疫功能低下的患者远离医疗机构,减少住院治疗,并加强医院对COVID-19患者和其他病症患者的能力。本文从可行性和临床结果方面描述了这种干预措施。方法:本研究是对意大利克雷莫纳省确诊或疑似COVID-19感染的癌症患者进行描述性研究,这些患者在大流行的第一个高峰期间在家中得到帮助。我们设计了一个有组织的家庭护理系统,其中包括一个配备有家访车的医疗和护理团队,以及一名护士经理,负责筛选要求纳入项目的患者电话。团队在家中给予口服药物(化疗、TKis等),并配备了所有必要的工具,进行检查、检查生命体征、采集血液样本和鼻咽拭子进行COVID-19检测。结果:2020年3月23日至5月15日,71例癌症患者获得居家辅助(181次,平均2.5次,SD 1.6范围1-7)。所有人的症状都可以追溯到COVID感染,但只有26/71(37%)被发现为COVID+;轻症19/26(73%),重症住院7例,死亡2例。其余的病人都康复了。43/71(60%)在家中口服或皮下给药,未见特殊问题或毒性。16/28(57%)与COVID+患者一起生活的个体被发现为COVID+,而非同居的个体中没有人被发现为COVID+。结论:在家中提供癌症护理是可行的,不仅在健康危机期间,而且在流行病之后,对于减少医院就诊、减少患者和护理人员的旅行并提高他们的生活质量,可能特别有用。有必要对肿瘤学家庭护理进行进一步的实施研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Delivery of Cancer Care at Home during the First COVID-19 Pandemic in Italy: A Case Series Study (DomOnCOVID Project)
Background: Cancer represents a major risk factor for COVID-19 poor outcomes. During the crucial phase of the pandemic, we launched a home care project, called DomOnCOVID, aiming to provide care to patients in their own homes, enabling to keep immunocompromised individuals away from health care facilities, decrease hospital use, and strengthen hospital capacity for subjects with COVID-19 and other conditions. This paper describes this intervention in terms of feasibility and clinical outcomes. Methods: This is a descriptive study of cancer patients with confirmed or suspected COVID-19 infection assisted at home in the Italian Province of Cremona during the pandemic’s first peak. We devised an organizational home care system which included a medical and nursing team equipped with a car for home visits, and a nurse manager who screened patient calls requesting inclusion in the project. The team administered oral drugs at home (chemotherapy, TKis, etc.) and was equipped with all necessary tools to conduct examinations, check vital signs, take blood samples, and nasopharyngeal swabs for COVID-19 testing. Results: From March 23rd to May 15th 2020, 71 cancer patients were assisted at home (181 visits, mean 2.5, SD 1.6 range 1-7). All had symptoms that could be traced back to COVID infection, but only 26/71 (37%) were found to be COVID+; 19/26 (73%) had mild symptoms, while 7 with severe symptoms were hospitalized and 2 died for COVID-19. The remaining patients recovered. 43/71 (60%) received at home oral or subcutaneous drugs and no particular problems or toxicity were observed. 16/28 (57%) of individuals living with COVID+ patients were found to be COVID+, while none of the non-cohabiting were COVID+. Conclusion: Delivery of cancer care at home is feasible and may be particularly useful not only during health crises but also after the epidemic in order to reduce hospital access, patient and care-giver travel and improve their quality of life. Further implementation studies on home-based care in oncology are warranted.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Disseminated Thymic Carcinoma: Case Report and Discussion on Problems of Treatment What is the Obstetric Outcome with a Large Loop Excision of the Transformation Zone (LLETZ) for Cervical Intraepithelial Neoplasia? Effects of DSPP and MMP20 Silencing on Key Signaling Pathways in Oral Squamous Cell Carcinoma Cells Multifaceted Networking of The Orphan Receptor Estrogen-Related Receptor Β in Breast Cancer Progression Current CT and MRI Applications in the Diagnosis of Bladder Cancer: A Review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1